V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20166092 | 20063579 | 1.55 | 85.8 | Curative (C) | 2016-04-05 | 2016-04-19 | ECX | N | null | ECX | 101419075 |
| 20166094 | 20063580 | 1.8 | 64.4 | Palliative (P) | 2019-06-28 | 2019-06-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101853053 |
| 20166095 | 20063581 | 1.58 | 75.8 | Neo-adjuvant (N) | 2018-03-26 | 2018-03-29 | ECX | 02 | N | ECX | 101224418 |
| 20166105 | 20063582 | 1.52 | 74 | Curative (C) | 2019-02-28 | 2019-03-05 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101020321 |
| 20166107 | 20063583 | 1.62 | 62.1 | Palliative (P) | 2020-01-03 | 2020-01-04 | ECX | 2 | N | ECX | 100011466 |
| 20166110 | 20063584 | 1.72 | 72.4 | Neo-adjuvant (N) | 2016-05-06 | 2016-05-24 | ECX | N | null | ECX | 101470831 |
| 20166112 | 20063585 | 1.57 | 92 | Palliative (P) | 2016-11-10 | 2016-11-26 | ECX | 2 | N | ECX | 100194620 |
| 20166113 | 20063586 | 1.77 | 71 | Adjuvant (A) | 2016-02-19 | 2016-03-11 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100331380 |
| 20166115 | 20063587 | 1.63 | 83.6 | Neo-adjuvant (N) | 2019-10-08 | 2019-10-26 | ECX | N | N | ECX | 100539540 |
| 20166120 | 20063588 | 1.73 | 62.7 | Palliative (P) | 2018-07-22 | 2018-08-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101180235 |
| 20166121 | 20063589 | 1.53 | 61 | 03 | 2017-07-13 | 2017-07-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101232873 |
| 20166142 | 20063590 | 1.78 | 106.8 | Palliative (P) | 2017-05-22 | 2017-06-19 | ECX | 02 | N | ECX | 100048451 |
| 20166145 | 20063591 | 1.51 | 56 | null | 2018-10-01 | 2018-10-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101433092 |
| 20166151 | 20063592 | 1.7 | 48.5 | Neo-adjuvant (N) | 2016-09-03 | 2016-09-09 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100731243 |
| 20166152 | 20063593 | 1.71 | 81.8 | Neo-adjuvant (N) | 2017-05-12 | 2017-05-19 | ECX | N | N | ECX | 101518460 |
| 20166154 | 20063594 | 1.78 | 69 | Neo-adjuvant (N) | 2018-08-25 | 2018-08-25 | ECX | N | N | ECX | 101395798 |
| 20166155 | 20063595 | 1.63 | 60.25 | Palliative (P) | 2017-03-15 | 2017-03-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100943572 |
| 20166157 | 20063596 | 1.73 | 57 | Adjuvant (A) | 2019-01-21 | 2019-02-04 | ECX | N | N | ECX | 100732200 |
| 20166160 | 20063597 | 1.77 | 81.8 | Palliative (P) | 2017-10-20 | 2017-11-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101244685 |
| 20166161 | 20063598 | null | 60.7 | Adjuvant (A) | 2016-06-27 | 2016-07-16 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101556856 |
| 20166162 | 20063599 | 1.54 | 50.7 | Neo-adjuvant (N) | 2019-03-09 | 2019-03-26 | ECX | N | N | ECX | 100584591 |
| 20166164 | 20063600 | 1.6 | 43.6 | Adjuvant (A) | 2017-12-02 | 2017-12-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101393995 |
| 20166165 | 20063601 | 1.6 | 42.7 | Palliative (P) | 2019-01-06 | 2019-01-08 | ECX | 02 | null | ECX | 101123138 |
| 20166177 | 20063602 | 1.83 | 63 | Palliative (P) | 2018-06-24 | 2018-06-24 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101798058 |
| 20166178 | 20063603 | 1.62 | 57 | Palliative (P) | 2017-04-27 | 2017-05-02 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100972562 |
| 20166186 | 20063604 | 1.56 | 55.8 | Palliative (P) | 2019-08-12 | 2019-08-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101641221 |
| 20166193 | 20063605 | 1.57 | 52 | Curative (C) | 2017-10-17 | 2017-10-17 | ECX | N | N | ECX | 100784489 |
| 20166197 | 20063606 | 1.8 | 71.4 | Adjuvant (A) | 2017-01-13 | 2017-01-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100131194 |
| 20166203 | 20063607 | 1.6 | 71 | Neo-adjuvant (N) | 2019-02-01 | 2019-02-01 | ECX | 2 | N | ECX | 101377571 |
| 20166204 | 20063608 | 1.67 | 119 | Neo-adjuvant (N) | 2016-05-28 | 2016-05-28 | ECX | 02 | N | ECX | 100619494 |
| 20166207 | 20063609 | null | null | null | 2019-10-23 | 2019-11-07 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100325211 |
| 20166214 | 20063610 | 1.66 | 63.6 | null | 2016-11-18 | 2016-12-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101348751 |
| 20166215 | 20063611 | 1.86 | 69.1 | Palliative (P) | 2017-11-12 | 2017-11-28 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101826846 |
| 20166218 | 20063612 | 1.77 | 47.8 | Neo-adjuvant (N) | 2016-08-23 | 2016-08-28 | ECX | 2 | N | ECX | 101691656 |
| 20166221 | 20063613 | 1.75 | 82 | Palliative (P) | 2019-03-20 | 2019-04-11 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100020684 |
| 20166222 | 20063614 | 1.65 | 71.8 | Palliative (P) | 2018-11-18 | 2018-11-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101253630 |
| 20166225 | 20063615 | null | null | Neo-adjuvant (N) | 2019-10-18 | 2019-10-24 | ECX | N | N | ECX | 100607514 |
| 20166227 | 20063616 | 1.7 | 65.3 | Adjuvant (A) | 2016-04-28 | 2016-04-28 | ECX | 02 | N | ECX | 101694894 |
| 20166231 | 20063617 | 1.63 | 75.3 | Palliative (P) | 2017-06-03 | 2017-07-27 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101835644 |
| 20166239 | 20063618 | 1.66 | 69 | Palliative (P) | 2017-12-28 | 2017-12-30 | ECX | 02 | null | ECX | 101203085 |
| 20166243 | 20063619 | 1.83 | 43.6 | 02 | 2018-03-10 | 2018-03-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101221658 |
| 20166248 | 20063620 | 1.51 | 73 | Adjuvant (A) | 2016-11-26 | 2016-11-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100514825 |
| 20166250 | 20063621 | 1.58 | 83.5 | Palliative (P) | 2018-09-09 | 2018-09-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100252431 |
| 20166254 | 20063622 | 1.57 | 70.2 | Neo-adjuvant (N) | 2015-12-06 | 2018-11-14 | ECX | 02 | N | ECX | 100256445 |
| 20166259 | 20063623 | 1.56 | 85.7 | Palliative (P) | 2019-11-27 | 2019-12-07 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100078677 |
| 20166261 | 20063624 | 1.73 | 87.5 | Palliative (P) | 2016-06-22 | 2016-06-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101245099 |
| 20166274 | 20063625 | 1.73 | 63 | Adjuvant (A) | 2017-11-15 | 2017-11-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101441991 |
| 20166275 | 20063626 | 1.77 | 80 | Adjuvant (A) | 2019-12-05 | 2019-12-05 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101653445 |
| 20166278 | 20063627 | 1.8 | 79.7 | Palliative (P) | 2019-11-23 | 2019-11-26 | ECX | N | N | ECX | 100339965 |
| 20166282 | 20063628 | 1.62 | 55.9 | Neo-adjuvant (N) | 2017-09-22 | 2017-10-01 | ECX | N | N | ECX | 100020409 |